Literature DB >> 10053058

Carbamylated hemoglobin interference in glycohemoglobin assays.

C W Weykamp, K Miedema, T de Haan, C J Doelman.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10053058

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  8 in total

1.  Lack of precision in HbA(1c) values on variant II in cases of hemoglobin Q India.

Authors:  P K Nigam; S Sharma; R Sareen; V Paul; A Lal
Journal:  Indian J Clin Biochem       Date:  2006-09

2.  Multicentre evaluation of the Premier Hb9210 HbA1c analyser.

Authors:  W Garry John; Randie Little; David B Sacks; Cas Weykamp; Erna Lenters-Westra; Theresa Hornsby; Zhen Zhao; Carla Siebelder; Alethea Tennill; Emma English
Journal:  Clin Chem Lab Med       Date:  2015-02       Impact factor: 3.694

3.  Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy.

Authors:  Henrik Andreas Bergrem; Tone Gretland Valderhaug; Anders Hartmann; Jøran Hjelmesaeth; Torbjørn Leivestad; Harald Bergrem; Trond Jenssen
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-04       Impact factor: 8.237

4.  In-depth comparative characterization of hemoglobin glycation in normal and diabetic bloods by LC-MSMS.

Authors:  Shih-Hao Wang; Tzu-Fan Wang; Chih-Hsing Wu; Shu-Hui Chen
Journal:  J Am Soc Mass Spectrom       Date:  2014-02-28       Impact factor: 3.109

5.  Labile glycated haemoglobin and carbamylated haemoglobin are still critical points for HbA1c measurement.

Authors:  Aurore Desmons; Stéphane Jaisson; Nathalie Leroy; Philippe Gillery; Emmanuelle Guillard
Journal:  Biochem Med (Zagreb)       Date:  2017-06-15       Impact factor: 2.313

Review 6.  Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease.

Authors:  James Ling; Jack K C Ng; Juliana C N Chan; Elaine Chow
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-22       Impact factor: 6.055

7.  Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients.

Authors:  Szu-Ying Lee; Yin-Cheng Chen; I-Chieh Tsai; Chung-Jen Yen; Shu-Neng Chueh; Hsueh-Fang Chuang; Hon-Yen Wu; Chih-Kang Chiang; Hui-Teng Cheng; Kuan-Yu Hung; Jenq-Wen Huang
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

8.  Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Mellitus and CKD.

Authors:  Lubaina Presswala; Susana Hong; Yael Harris; Isabela Romao; Meng Zhang; Kenar D Jhaveri; Vipul Sakhiya; Steven Fishbane
Journal:  Kidney Med       Date:  2019-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.